Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jul;58(7):835-838.
doi: 10.1038/s41409-023-01981-x. Epub 2023 Apr 12.

Haploidentical allogeneic stem cell transplantation with post-transplant cyclophosphamide and subsequent kidney transplant for patients with severe sickle cell disease with end-stage kidney disease (ESKD)

Alexandra Gomez-Arteaga  1 , Nina Orfali  2   3 , Michelle Pasciolla  4 , Ayanna Baptiste  5 , Inna Guindine  2 , Jingmei Hsu  2 , Jonathan Lin  6   7 , Sebastian A Mayer  2 , Adrienne A Phillips  2 , Tsiporah B Shore  2 , Paul D Simonson  8 , Edward DiCarlo  9 , Sung Yoon  2 , Thangamani Muthukumar  6   7 , Koen van Besien  2
Affiliations

Haploidentical allogeneic stem cell transplantation with post-transplant cyclophosphamide and subsequent kidney transplant for patients with severe sickle cell disease with end-stage kidney disease (ESKD)

Alexandra Gomez-Arteaga et al. Bone Marrow Transplant. 2023 Jul.
No abstract available

PubMed Disclaimer

References

    1. Aydin M, Dovern E, Leeflang MMG, de la Fuente J, Kassim AA, Biemond BJ, et al. Haploidentical Allogeneic Stem Cell Transplantation in Sickle Cell Disease: A Systematic Review and Meta-Analysis. Transplant Cell Ther. 2021;27:e1001–4. https://doi.org/10.1016/j.jtct.2021.09.009 . - DOI
    1. Bolaños-Meade J, Cooke KR, Gamper CJ, Ali SA, Ambinder RF, Borrello IM, et al. Effect of increased dose of total body irradiation on graft failure associated with HLA-haploidentical transplantation in patients with severe haemoglobinopathies: a prospective clinical trial. Lancet Haematol. 2019;6:e183–e193. https://doi.org/10.1016/S2352-3026(19)30031-6 . - DOI - PubMed - PMC
    1. de la Fuente J, Dhedin N, Koyama T, Bernaudin F, Kuentz M, Karnik L, et al. Haploidentical Bone Marrow Transplantation with Post-Transplantation Cyclophosphamide Plus Thiotepa Improves Donor Engraftment in Patients with Sickle Cell Anemia: Results of an International Learning Collaborative. Biol Blood Marrow Transplant. 2019;25:1197–209. https://doi.org/10.1016/j.bbmt.2018.11.027 . - DOI - PubMed
    1. Patel C, Pasciolla M, Abramova R, Salerno D, Arteaga AG, Shore TB, et al. Pre-hematopoietic stem cell transplant rituximab for Epstein-Barr Virus and post-transplant lymphoproliferative disorder prophylaxis in alemtuzumab recipients. Transplant Cell Therap. 2022. https://doi.org/10.1016/j.jtct.2022.10.023 .
    1. Stenger EO, Shenoy S, Krishnamurti L. How I treat sickle cell disease with hematopoietic cell transplantation. Blood. 2019;134:2249–60. https://doi.org/10.1182/blood.2019000821 . - DOI - PubMed - PMC

MeSH terms

Substances

LinkOut - more resources